James Bailey
Family Medicine · Post Falls, IDNPI 1194112375
Payments from drug & device makers
Across 158 payments — averaging $14.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$809
- Amgen$335
- Abbott$236
- Lilly USA, LLC$165
- Otsuka Pharmaceutical Development & Commercialization, Inc.$129
- Mayne Pharma Commercial LLC$90
- plus $488 from 13 others
What the payments were for
- Food & beverage$2,14095%
- Education$1125%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 94 | $809 |
| Amgen | 18 | $335 |
| Abbott | 12 | $236 |
| Lilly USA, LLC | 12 | $165 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $129 |
| Mayne Pharma Commercial LLC | 2 | $90 |
| Novo Nordisk | 2 | $84 |
| Ascendis Pharma Endocrinology Inc | 1 | $71 |
| Kyowa Kirin, Inc. | 1 | $60 |
| Axsome Therapeutics, Inc. | 1 | $59 |
| AstraZeneca | 1 | $53 |
| Acadia Pharmaceuticals Inc | 1 | $40 |
| Sumitomo Pharma America, Inc. | 4 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Novartis | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Merck | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
How this compares
$2,252 in reported general payments places this provider in the 85th percentile of 803 family medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prolastin CAlpha-1-Proteinase Inhibitor | 13 | $153,726 |
| OzempicSemaglutide | 29 | $34,943 |
| MounjaroTirzepatide | 27 | $28,452 |
| JardianceEmpagliflozin | 19 | $23,641 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,071 |
| MyrbetriqMirabegron | 11 | $4,968 |
| Duloxetine Hcl | 24 | $1,237 |
| Atorvastatin Calcium | 67 | $892 |
| Rosuvastatin Calcium | 65 | $841 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $764 |
| Pravastatin Sodium | 30 | $747 |
| Trazodone Hcl | 35 | $713 |
| Irbesartan | 48 | $712 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 16 | $616 |
| Amlodipine Besylate | 44 | $555 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $84 | $34,94329 claims |
| Lilly USA, LLCMounjaro | $165 | $28,45227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 803 family medicine providers in Idaho.
Other family medicine in Post Falls
- Michael MonohanPost Falls$8K
- Morgan FordPost Falls$8K
- Anthony PetersPost Falls$6K
- Chad ScarolaPost Falls$6K
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.